Showing results (31-40 of 59) with videos related to
Sort By:
Pageof 6
Cancer Discovery|December 12, 2012
Noncovalent wild-type-sparing inhibitors of EGFR T790MHo-June Lee, Gabriele Schaefer, Timothy P Heffron, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2005
Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patientsRobert L Yauch, Thomas Januario, David A Eberhard, et al.Toxicology and Applied Pharmacology|July 15, 2023
Smarca2 genetic ablation is phenotypically benign in a safety assessment of tamoxifen-inducible conditional knockout ratsJonathan Maher, Nicola Stagg, Gary Cain, et al.Cancer Research|December 3, 2010
Small molecule inhibition of GDC-0449 refractory smoothened mutants and downstream mechanisms of drug resistanceGerrit J P Dijkgraaf, Bruno Alicke, Lasse Weinmann, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2012
A randomized phase II trial of vismodegib versus placebo with FOLFOX or FOLFIRI and bevacizumab in patients with previously untreated metastatic colorectal cancerJordan Berlin, Johanna C Bendell, Lowell L Hart, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2012
DNA methylation profiling defines clinically relevant biological subsets of non-small cell lung cancerKim Walter, Thomas Holcomb, Tom Januario, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2013
Loss of NAPRT1 expression by tumor-specific promoter methylation provides a novel predictive biomarker for NAMPT inhibitorsDavid S Shames, Kristi Elkins, Kimberly Walter, et al.Nature|August 30, 2008
A paracrine requirement for hedgehog signalling in cancerRobert L Yauch, Stephen E Gould, Suzie J Scales, et al.The New England Journal of Medicine|September 4, 2009
Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449Charles M Rudin, Christine L Hann, John Laterra, et al.Nature|April 15, 2026
Template-driven scaffolding of SCF<sup>FBXO42</sup> regulates PP2A degradationSebastien Coassolo, Nairie Michaelian, Timurs Maculins, et al.Pageof 6